RK
Ramkumar Kanmanipriya
About Ramkumar Kanmanipriya
Data last updated:
Ramkumar Kanmanipriya was a Director at Cu-V-Kar Genetic Medicine Private Limited (2007–2019), Director at Viencee Pharma Science Private Limited (2019–2022) and Director at Hfa Formulations Private Limited (2015–2021). The companies operate in Pharma.
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 04 Jan 2007 | 2007 | ₹55.11 Cr (FY 2024) | Active | |
| Director | 14 Jun 2019 | 2017 | ₹1.54 Cr (FY 2024) | Active | |
| Director | 03 Feb 2015 | 2015 | ₹15.65 Cr (FY 2024) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ramkumar Kanmanipriya
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ramkumar Kanmanipriya
Ramkumar Kanmanipriya was first appointed on 04 Jan 2007 as Director at Cu-V-Kar Genetic Medicine Private Limited. The most recent appointment on record is 14 Jun 2019 at Viencee Pharma Science Private Limited.
Ramkumar Kanmanipriya held 3 earlier board appointments: Cu-V-Kar Genetic Medicine Private Limited (Director, 04 Jan 2007 to 09 Aug 2019); Viencee Pharma Science Private Limited (Director, 14 Jun 2019 to 21 Mar 2022); Hfa Formulations Private Limited (Director, 03 Feb 2015 to 29 Apr 2021).